D69 Purpura and other hemorrhagic conditions

Name of the Condition

• Purpura and other hemorrhagic conditions

Summary

Purpura and other hemorrhagic conditions refer to a group of disorders characterized by abnormal bleeding or bruising due to issues with blood clotting or blood vessel integrity. These conditions may involve platelet abnormalities, coagulation factor deficiencies, or vascular fragility, leading to visible signs of bleeding under the skin or mucous membranes.

Causes

Purpura and hemorrhagic conditions can arise from various underlying mechanisms, including immune-mediated destruction of platelets, genetic or acquired defects in clotting factors, infections, medications, or structural abnormalities in blood vessels. The specific cause often determines the type and severity of the condition.

Risk Factors

• Underlying autoimmune disorders (e.g., lupus, rheumatoid arthritis)
• Certain medications (e.g., anticoagulants, antiplatelet drugs)
• Infections (e.g., viral or bacterial)
• Chronic conditions affecting bone marrow or liver function
• Family history of bleeding disorders

Symptoms

• Unexplained bruising (purpura) or petechiae (small red/purple spots)
• Prolonged bleeding from minor cuts or injuries
• Nosebleeds or bleeding gums
• Blood in urine or stools
• Excessive menstrual bleeding
• Fatigue or weakness (if anemia develops)

Diagnosis

Diagnosis typically involves a combination of clinical evaluation, blood tests (e.g., complete blood count, coagulation studies), and imaging or tissue samples to identify the underlying cause. Additional tests may include platelet function assays, bone marrow biopsy, or specific antibody screens depending on suspected etiology.

Treatment Options

Treatment focuses on addressing the underlying cause and managing symptoms. Options may include:

• Medications to suppress immune responses or boost platelet production
• Transfusions of platelets or clotting factors
• Discontinuation of triggering medications
• Supportive care for bleeding episodes
• Management of associated conditions (e.g., infection control)

Prognosis and Follow-Up

Prognosis varies widely based on the specific condition and its cause. Some cases resolve with treatment, while others may require long-term management. Regular follow-up with a healthcare provider is essential to monitor for recurrence, complications, or progression of underlying diseases.

Complications

• Severe bleeding (e.g., intracranial hemorrhage)
• Chronic anemia from persistent blood loss
• Organ damage due to uncontrolled bleeding
• Increased risk of infections (if immunosuppressive treatments are used)

Lifestyle & Prevention

• Avoid activities with high injury risk
• Use soft toothbrushes and electric razors to minimize bleeding
• Follow medication guidelines carefully
• Maintain a balanced diet to support overall health
• Report new or worsening symptoms promptly

When to Seek Professional Help

Seek immediate medical attention for:

• Sudden, severe bruising or unexplained bleeding
• Headaches, dizziness, or confusion (possible internal bleeding)
• Persistent or heavy bleeding that doesn’t stop with pressure
• Signs of infection (e.g., fever, chills) if on immunosuppressive therapy

Tips for Medical Coders

When coding for D69 (Purpura and other hemorrhagic conditions), ensure documentation supports the specific subtype or underlying cause when available. Note whether the condition is acute, chronic, or secondary to another disorder. Include details on clinical presentation, diagnostic findings, and treatment to justify code selection. Verify that no more specific code (e.g., for immune thrombocytopenic purpura) applies before using D69.